51. Incidence and prognostic significance of non enhancing cortical flair hyperintensity in glioblastoma.
- Author
-
Tacey M., Stuckey S., Drummond K., Gaillard F., Lasocki A., Tacey M., Stuckey S., Drummond K., Gaillard F., and Lasocki A.
- Abstract
PURPOSE: To determine the incidence and prognostic implications of non-enhancing cortical FLAIR (fluid attenuated inversion recovery) hyperintensity in histologically-proven glioblastomas. MATERIALS AND METHODS: Institutional Human Research Ethics Committee approval was obtained. Patients with a new diagnosis of glioblastoma between September 2007 and December 2010 were identified. Only patients with at least FLAIR and post-contrast T1-weighted sequences were included. Pre-operative Magnetic Resonance Imaging studies were reviewed together by two readers to determine whether there was evidence of non-enhancing cortical signal abnormality, based primarily on the FLAIR sequence. It was graded as either 'negative', 'minor' (a thin rim around enhancing tumour) or 'more extensive'. Patient survival was then compared between groups, correcting for age, sex, performance status, axial measurements of the largest enhancing lesion and location (deep, periventricular or peripheral). RESULT(S): 151 patients met the inclusion criteria. 77 patients (51%) had evidence of non-enhancing cortical signal abnormality - minor in 37 of these patients (median survival 220 days) and more extensive in 40 (median survival 310 days). The 74 patients without non-enhancing cortical signal abnormality had a median survival of 261 days. On multivariate analysis, there was no significant difference in survival between the three groups (p=0.109 comparing 'negative' and 'minor'; p=0.399 comparing 'negative' and 'more extensive'). The only significant differences in survival were when assessing only patients with peripherally-located enhancing lesions, when the presence of non-enhancing cortical signal abnormality was associated with worse survival (hazard ratio=3.4, p=0.003 for 'minor'; HR=2.3, p=0.038 for 'more extensive'). CONCLUSION(S): Non-enhancing cortical signal abnormality is common in glioblastoma, occurring in about half of cases. In general, its presence does not alter survival, and facto
- Published
- 2015